Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transforming Preeclampsia Care: Molecular Diagnostics and Therapeutic Innovations.

Journal of the American Society of Nephrology : JASN·2026

Same author

Maternal and fetal HLA heterozygosity in preeclampsia: Insights from a large multi-ancestry pregnancy cohort.

medRxiv : the preprint server for health sciences·2026

Same author

The role of supraoptic hypothalamic arginine vasopressin neurons in aging-associated water balance and thermoregulatory deficits in male mice.

Nature communications·2026

Same author

Placental nicotinamide adenine dinucleotide modulates the timing of labor.

Science (New York, N.Y.)·2026

Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026

Same author

Fetal sex-specific differences in the placental transcriptome of gestational diabetes.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Angiogenic factors and preeclampsia.

Guy Steinberg¹, Eliyahu V Khankin, S Ananth Karumanchi

¹Departments of Obstetrics & Gynecology, Boston, MA 02215, USA.

Thrombosis Research

|February 17, 2009

Summary

Preeclampsia is linked to placental anti-angiogenic proteins like soluble Fms-like tyrosine kinase 1 (sFlt1). Identifying these biomarkers may help screen for preeclampsia risk and guide future treatments.

Area of Science:

Obstetrics and Gynecology
Maternal-Fetal Medicine
Cardiovascular Research

Background:

Preeclampsia/eclampsia is a significant global cause of maternal and fetal illness.
High levels of placental anti-angiogenic proteins, such as soluble Fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin, are associated with preeclampsia phenotypes.
Elevated sFlt1 and soluble endoglin levels precede clinical preeclampsia onset, suggesting their potential as early screening biomarkers.

Purpose of the Study:

To explore the role of anti-angiogenic proteins in preeclampsia.
To investigate the potential of sFlt1 and soluble endoglin as biomarkers for preeclampsia risk identification.
To review current research on pharmacologic interventions targeting sFlt1 and soluble endoglin.

Main Methods:

More Related Videos

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Experiment Videos

Last Updated: Jun 25, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Review of existing literature on preeclampsia etiology and biomarkers.
Analysis of the role of circulating anti-angiogenic factors in preeclampsia pathogenesis.
Examination of novel pathways involved in sFlt1 production.

Main Results:

Circulating levels of sFlt1 and soluble endoglin are implicated in preeclampsia.
Specific isoforms like sFlt1-14, found in primates, are potentially key in preeclampsia.
The precise role of newly proposed pathways in human preeclampsia remains undetermined.

Conclusions:

sFlt1 and soluble endoglin show promise as biomarkers for preeclampsia screening and risk assessment.
Further research is needed to elucidate the exact role of novel pathways in sFlt1 production.
Women with a history of preeclampsia face increased long-term risks for hypertension and cardiovascular/renal diseases, with the underlying mechanisms still under investigation.